Endocrine profile and phenotype-genotype correlation in unrelated patients with non-classical congenital adrenal hyperplasia

Clinical Biochemistry

Volumn 44, Issue 12, 2011, Pages 959-963

  Skordis, Nicos ^a,b   Shammas, Christos ^b   Efstathiou, Elisavet ^b   Kaffe, Katerina ^b   Neocleous, Vassos ^b   Phylactou, Leonidas A ^b  

^a Makarios III Hospital   (Cyprus)

^b CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

Author keywords

17 OHP; CYP21A2; Increment4; NC CAH; Testosterone

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CYTOCHROME P450 1A2; DNA; HYDROXYPROGESTERONE; PRASTERONE SULFATE; TESTOSTERONE;

ADOLESCENT; ADULT; ARTICLE; BIOCHEMISTRY; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONGENITAL ADRENAL HYPERPLASIA; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC COUNSELING; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; MALE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NON CLASSICAL CONGENITAL ADRENAL HYPERPLASIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

17-ALPHA-HYDROXYPROGESTERONE; ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; ANDROSTENEDIONE; CHILD; CYPRUS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; MALE; MUTATION; SEVERITY OF ILLNESS INDEX; STEROID 21-HYDROXYLASE; TESTOSTERONE;

EID: 79960313396     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.05.013     Document Type: Article

References (50)

1. Merke D.P., Bornstein S.R. Congenital adrenal hyperplasia. Lancet 2005, 365:2125-2136.
2. Speiser P.W., White P.C. Congenital adrenal hyperplasia. N Engl J Med 2003, 349:776-788.
3. Forest M.G. Recent advances in the diagnosis and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Reprod Update 2004, 10:469-485.
4. Morel Y., Miller W.L. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv Hum Genet 1991, 20:1-68.
5. Carroll M.C., Campbell R.D., Porter R.R. Mapping of steroid 21-hydroxylase genes adjacent to complement component C4 genes in HLA, the major histocompatibility complex in man. Proc Natl Acad Sci USA 1985, 82:521-525.
6. Urabe K., Kimura A., Harada F., Iwanaga T., Sasazuki T. Gene conversion in steroid 21-hydroxylase genes. Am J Hum Genet 1990, 46:1178-1186.
7. Van Der Kamp H.J., Wit J.M. Neonatal screening for congenital adrenal hyperplasia. Eur J Endocrinol 2004, 151(Suppl 3):U71-U75.
8. Pang S. Congenital adrenal hyperplasia. Endocrinol Metab Clin North Am 1997, 26:853-891.
9. Higashi Y., Yoshioka H., Yamane M., Gotoh O., Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA 1986, 83:2841-2845.
10. White P.C., New M.I., Dupont B. Structure of human steroid 21-hydroxylase genes. Proc Natl Acad Sci USA 1986, 83:5111-5115.
11. Donohoue P.A., Jospestar N., Migeonstar C.J., Van Dop C. Two distinct areas of unequal crossingover within the steroid 21-hydroxylase genes produce absence of CYP21B. Genomics 1989, 5:397-406.
12. Tusie-Luna M.T., Traktman P., White P.C. Determination of functional effects of mutations in the steroid 21-hydroxylase gene (CYP21) using recombinant vaccinia virus. J Biol Chem 1990, 265:20916-20922.
13. Wilson R.C., Mercado A.B., Cheng K.C., New M.I. Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 1995, 80:2322-2329.
14. Decourt J., Jayle M.F., Baulieu E. Clinically late virilism with excretion of pregnanetriol and insufficiency of cortisol production. Ann Endocrinol (Paris) 1957, 18:416-422.
15. Speiser P.W., Dupont B., Rubinstein P., Piazza A., Kastelan A., New M.I. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am J Hum Genet 1985, 37:650-667.
16. Witchel S.F., Azziz R. Nonclassic congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010, 2010:625105.
17. Bidet M., Bellanné-Chantelot C., Galand-Portier M.B., Tardy V., Billaud L., Laborde K. Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members. J Clin Endocrinol Metab 2009, 94:1570-1578.
18. Mercado A.B., Wilson R.C., Cheng K.C., Wei J.Q., New M.I. Prenatal treatment and diagnosis of congenital adrenal hyperplasia owing to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab 1995, 80:2014-2020.
19. Wedell A. Molecular genetics of congenital adrenal hyperplasia (21-hydroxylase deficiency): implications for diagnosis, prognosis and treatment. Acta Paediatr 1998, 87:159-164.
20. Krone N., Roscher A.A., Schwarz H.P., Braun A. Comprehensive analytical strategy for mutation screening in 21-hydroxylase deficiency. Clin Chem 1998, 44:2075-2082.
21. Wilson R.C., et al. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol Genet Metab 2007, 90:414-421.
22. Skordis N., Kyriakou A., Tardy V., Ioannou Y.S., Varvaresou A., Dracopoulou-Vabouli M., et al. Molecular defects of the CYP21A2 gene in Greek-Cypriot patients with congenital adrenal hyperplasia. Horm Res Paediatr 2011, 75:180-186.
23. Neocleous V., Ioannou Y.S., Bartsota M., Costi C., Skordis N., Phylactou L.A. Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia. Clin Biochem 2009, 42:1363-1367.
24. Dracopoulou-Vabouli M., Maniati-Christidi M., Dacou-Voutetakis C. The spectrum of molecular defects of the CYP21 gene in the Hellenic population: variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001, 86:2845-2848.
25. Speiser P.W., Dupont J., Zhu D., Serrat J., Buegeleisen M., Tusie-Luna M.T. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Invest 1992, 90:584-595.
26. White P.C., Vitek A., Dupont B., New M.I. Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA 1988, 85:4436-4440.
27. Wedell A., Stengler B., Luthman H. Characterization of mutations on the rare duplicated C4/CYP21 haplotype in steroid 21-hydroxylase deficiency. Hum Genet 1994, 94:50-54.
28. Globerman H., Amor M., Parker K.L., New M.I., White P.C. Nonsense mutation causing steroid 21-hydroxylase deficiency. J Clin Invest 1988, 82:139-144.
29. Chrousos G.P., Munabi A., Cutler G.B., Loriaux D.L. Late-onset 21-hydroxylase deficiency. Ann Intern Med 1982, 97:281.
30. Speiser P.W., Knochenhauer E.S., Dewailly D., Fruzzetti F., Marcondes J.A., Azziz R. A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype. Mol Genet Metab 2000, 71:527-534.
31. Azziz R., Sanchez L.A., Knochenhauer E.S., Moran C., Lazenby J., Stephens K.C. Androgen excess in women: experience with over 1000 consecutive patients. J Clin Endocrinol Metab 2004, 89:453-462.
32. Kuttenn F., Couillin P., Girard F., Billaud L., Vincens M., Boucekkine C. Late-onset adrenal hyperplasia in hirsutism. N Engl J Med 1985, 313:224-231.
33. Dolzan V., Sólyom J., Fekete G., Kovács J., Rakosnikova V., Votava F. Mutational spectrum of steroid 21-hydroxylase and the genotype-phenotype association in Middle European patients with congenital adrenal hyperplasia. Eur J Endocrinol 2005, 153:99-106.
34. Ezquieta B., Oliver A., Gracia R., Gancedo P.G. Analysis of steroid 21-hydroxylase gene mutations in the Spanish population. Hum Genet 1995, 96:198-204.
35. Carrera P., Bordone L., Azzani T., Brunelli V., Garancini M.P., Chiumello G. Point mutations in Italian patients with classic, non-classic, and cryptic forms of steroid 21-hydroxylase deficiency. Hum Genet 1996, 98:662-665.
36. Bachega T.A., Avey C.J., Conway G.S., Honour J.W. Molecular genotyping in Brazilian patients with the classical and nonclassical forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab 1998, 83:4416-4419.
37. Rumsby G., et al. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms. Clin Endocrinol (Oxf) 1998, 48:707-711.
38. Finkielstain G.P., et al. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 2011, 96:E161-E172.
39. Ezquieta B., Cueva E., Varela J., Oliver A., Fernández J., Jariego C. Non-classical 21-hydroxylase deficiency in children: association of adrenocorticotropic hormone-stimulated 17-hydroxyprogesterone with the risk of compound heterozygosity with severe mutations. Acta Paediatr 2002, 91:892-898.
40. Wasniewska M., Caruso M., Indovina S., Crisafulli G., Mirabelli S., Salzano G., et al. Salt-wasting congenital adrenal hyperplasia: genotypical peculiarities in a Sicilian ethnic group. J Endocrinol Invest 2008, 31:607-609.
41. Abid F., Tardy V., Gaouzi A., El Hessni A., Morel Y., Chabraoui L. CYP21A2 gene mutation analysis in Moroccan patients with classic form of 21-hydroxylase deficiency: high regional prevalence of p.Q318X mutation and identification of a novel p.L353R mutation. Clin Chem Lab Med 2008, 46:1707-1713.
42. Sadeghi F., Yurur-Kutlay N., Berberoglu M., Cetinkaya E., Aycan Z., Kara C. Identification of frequency and distribution of the nine most frequent mutations among patients with 21-hydroxylase deficiency in Turkey. J Pediatr Endocrinol Metab 2008, 21:781-787.
43. Wedell A., Thilén A., Ritzén E.M., Stengler B., Luthman H. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation. J Clin Endocrinol Metab 1994, 78:1145-1152.
44. Krone N., Braun A., Roscher A.A., Knorr D., Schwarz H.P. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany. J Clin Endocrinol Metab 2000, 85:1059-1065.
45. Balsamo A., Cacciari E., Baldazzi L., Tartaglia L., Cassio A., Mantovani V. CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region. Clin Endocrinol (Oxf) 2000, 53:117-125.
46. Tusie-Luna M.T., Speiser P.W., Dumic M., New M.I., White P.C. A mutation (Pro-30 to Leu) in CYP21 represents a potential nonclassic steroid 21-hydroxylase deficiency allele. Mol Endocrinol 1991, 5:685-692.
47. Lajic S., Clauin S., Robins T., Vexiau P., Blanché H., Bellanne-Chantelot C. Novel mutations in CYP21 detected in individuals with hyperandrogenism. J Clin Endocrinol Metab 2002, 87:2824-2829.
48. White P.C., Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000, 21:245-291.
49. Mornet E., Gibrat J.F. A 3D model of human P450c21: study of the putative effects of steroid 21-hydroxylase gene mutations. Hum Genet 2000, 106:330-339.
50. Janner M., Pandey A.V., Mullis P.E., Flück C.E. Clinical and biochemical description of a novel CYP21A2 gene mutation 962_963insA using a new 3D model for the P450c21 protein. Eur J Endocrinol 2006, 155:143-151.